Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P21 is annotated as a pseudogene derived from the ST13 gene, which encodes a co-chaperone that interacts with Hsp70 proteins. Pseudogenes do not typically produce functional proteins, and there is currently no evidence that ST13P21 encodes an active protein or plays a role as a therapeutic target. Because it is a pseudogene, it does not fit into conventional protein target or druggable target classes such as enzyme, receptor, or transporter. There is no established link to cellular biological function, disease roles, therapeutic drugs, or mechanisms of drug action. If you are seeking information about the functional ST13 gene or the Hsp70-interacting protein (HIP) itself, those refer to a different (protein-coding) gene and protein with known functions in protein folding and chaperone complexes[3]. Key point: ST13P21 is a pseudogene, not an active molecular target. The entry does not correspond to a conventional drug target, and there is no evidence of therapeutic, functional, or clinical relevance as of current database annotations[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST13, Hsp70 interacting protein pseudogene 21 (ST13P21).